What is α1-Acid Glycoprotein? α1-Acid Glycoprotein (AAG), also known as orosomucoid, is an acute-phase protein produced by the liver. It functions as a transport protein for drugs and endogenous compounds and is a biomarker of inflammation. Elevated AAG levels are associated with acute and chronic inflammatory conditions, infections, and malignancies.
Definition: The α1-Acid Glycoprotein Unit Converter converts AAG concentrations between various units, enabling standardization of laboratory results for clinical use.
Purpose: It assists clinicians and researchers in interpreting AAG levels across different measurement units (e.g., mmol/L to g/L), ensuring accurate assessment of inflammatory states and drug-binding capacity.
Converting AAG concentrations between units is critical for:
Elevated Levels: High AAG levels are seen in acute and chronic inflammation, infections, malignancies, and stress states (e.g., surgery, trauma). Low levels may occur in liver disease, malnutrition, or nephrotic syndrome.
Normal Ranges:
Interferences:
Q: Why are there different units for AAG?
A: Different units reflect varying standards; µmol/L is the SI unit, while g/L and mg/mL are commonly used in clinical practice.
Q: What is a normal AAG level?
A: Normal AAG is typically 0.4–1.2 g/L (10–30 µmol/L). Levels vary by context—consult a healthcare provider for interpretation.
Q: Can this converter be used for other proteins?
A: No, this converter is specific to AAG; other proteins have different conversion factors—consult a healthcare provider for accuracy.